FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Anagrelide Hydrochloride Capsules
Status: Currently in Shortage
»Date first posted: 10/29/2019
»Therapeutic Categories: Hematology

Expand all

Shire US Inc. now part of Takeda (New 10/29/2019)

Company Contact Information:
800-828-2088

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
AGRYLIN 0.5 mg Capsule,100 capsules in 1 bottle (NDC 54092-063-01) Available Takeda is actively working to mitigate a recent unexpected increase in demand for the product. Demand increase for the drug

Teva Pharmaceuticals (Revised 11/07/2019)

Company Contact Information:
800-545-8800

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1 MG 100 Capsules (NDC 0172-5240-60) Available and allocating inventory Rolling backorders into December 2019; Expected recovery February 2020 Requirements related to complying with good manufacturing practices
0.5 MG 100 Capsules (NDC 0172-5241-60) Available and allocating inventory Rolling backorders into November 2019; Expected recovery April 2020 Requirements related to complying with good manufacturing practices

Torrent Pharma Inc. (New 10/30/2019)

Company Contact Information:
908-280-3333

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
0.5 mg per capsule Bottles of 100 (NDC 13668-453-01) Available to ship in the week of Nov-11 Requirements related to complying with good manufacturing practices
1 mg per capsule, Bottles of 100 (NDC 13668-462-01) Available to ship in the week of Nov-4 Requirements related to complying with good manufacturing practices

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English